Fujii A, Yoneda M, Ito T, Yamamura O, Satomi S, Higa H, Kimura A, Suzuki M, Yamashita M, Yuasa T, Suzuki H, Kuriyama M
Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan.
J Neuroimmunol. 2005 May;162(1-2):130-6. doi: 10.1016/j.jneuroim.2005.02.004.
We investigated autoantibodies and their epitope(s) in Hashimoto's encephalopathy associated with Hashimoto's thyroiditis. In a proteomic analysis, they proved to recognize alpha-enolase. We further searched the epitope region in alpha-enolase using different regions of recombinant proteins expressed in cultured human cells. The amino terminal region was recognized by autobodies from a much higher proportion of patients with Hashimoto's encephalopathy (83.3%; 5/6) than from patients with Hashimoto's thyroiditis (11.8%; 2/17), and not at all by sera from controls (25 healthy individuals and 25 controls with other neurological disorders) (0%; 0/50). Neither the carboxyl terminal nor the mid-region of alpha-enolase showed specificity for Hashimoto's encephalopathy. Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker for Hashimoto's encephalopathy.
我们研究了与桥本甲状腺炎相关的桥本脑病中的自身抗体及其表位。在蛋白质组学分析中,它们被证明可识别α-烯醇化酶。我们使用在培养的人细胞中表达的重组蛋白的不同区域,进一步搜索α-烯醇化酶中的表位区域。与桥本甲状腺炎患者(11.8%;2/17)相比,来自更高比例的桥本脑病患者(83.3%;5/6)的自身抗体识别α-烯醇化酶的氨基末端区域,而对照组(25名健康个体和25名患有其他神经系统疾病的对照)的血清则完全不识别(0%;0/50)。α-烯醇化酶的羧基末端和中间区域均未显示出对桥本脑病的特异性。针对α-烯醇化酶氨基末端的自身抗体是桥本脑病的一种有用的诊断标志物。